Front Row Advisors LLC Novartis Ag Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $53,732 - $61,177	564 New	564 $54,000
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $2,747 - $3,048	29 Added 6.92%	448 $45,000
Q1 2023 May 22, 2023	BUY	$80.03 - $92.81 $30,411 - $35,267	380 Added 974.36%	419 $39,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $30,651 - $35,546	-383 Reduced 90.76%	39 $42,000
Q4 2022 Feb 15, 2023	SELL	$75.55 - $92.52 $5,741 - $7,031	-76 Reduced 15.26%	422 $38,000
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $10,296 - $12,041	138 Added 38.33%	498 $38,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $966 - $1,125	-12 Reduced 3.23%	360 $30,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $320 - $362	-4 Reduced 1.06%	372 $32,000
Q4 2021 Mar 09, 2022	BUY	$79.7 - $88.13 $1,992 - $2,203	25 Added 7.12%	376 $33,000
Q2 2021 Aug 23, 2021	SELL	$85.24 - $94.15 $6,648 - $7,343	-78 Reduced 18.18%	351 $33,000
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $83 - $98	-1 Reduced 0.23%	429 $37,000
Q3 2020 Nov 30, 2020	SELL	$82.14 - $91.0 $14,703 - $16,289	-179 Reduced 29.39%	430 $39,000
Q2 2020 Aug 17, 2020	BUY	$80.93 - $91.1 $7,688 - $8,654	95 Added 18.48%	609 $53,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $7,279 - $10,198	103 Added 25.06%	514 $44,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $2,361 - $2,670	-28 Reduced 6.38%	411 $39,000
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $3,250 - $3,581	-38 Reduced 7.97%	439 $38,000
Q2 2019 Aug 27, 2019	SELL	$75.4 - $92.8 $1,809 - $2,227	-24 Reduced 4.79%	477 $44,000
Q1 2019 May 17, 2019	BUY	$75.32 - $86.15 $677 - $775	9 Added 1.83%	501 $48,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $17,236 - $19,192	234 Added 90.7%	492 $42,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $2,008 - $2,322	30 Added 13.16%	258 $22,000
Q2 2018 Jul 31, 2018	BUY	$64.91 - $73.36 $1,817 - $2,054	28 Added 14.0%	228 $19,000
Q4 2017 Feb 01, 2018	BUY	$72.33 - $77.64 $14,466 - $15,528	200	200 $17,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account